DK0527760T3 - Fremgangsmåder og præparater til vaccination mod HIV - Google Patents

Fremgangsmåder og præparater til vaccination mod HIV

Info

Publication number
DK0527760T3
DK0527760T3 DK91907077.1T DK91907077T DK0527760T3 DK 0527760 T3 DK0527760 T3 DK 0527760T3 DK 91907077 T DK91907077 T DK 91907077T DK 0527760 T3 DK0527760 T3 DK 0527760T3
Authority
DK
Denmark
Prior art keywords
methods
preparations
against hiv
vaccination against
env
Prior art date
Application number
DK91907077.1T
Other languages
English (en)
Inventor
Timothy J Gregory
Phillip W Berman
Brian M Fendly
Florian M Wurm
Original Assignee
Genentech Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=24007729&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DK0527760(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Genentech Inc filed Critical Genentech Inc
Application granted granted Critical
Publication of DK0527760T3 publication Critical patent/DK0527760T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/08—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from viruses
    • C07K16/10—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from viruses from RNA viruses
    • C07K16/1036—Retroviridae, e.g. leukemia viruses
    • C07K16/1045—Lentiviridae, e.g. HIV, FIV, SIV
    • C07K16/1063—Lentiviridae, e.g. HIV, FIV, SIV env, e.g. gp41, gp110/120, gp160, V3, PND, CD4 binding site
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/30—Immunoglobulins specific features characterized by aspects of specificity or valency
    • C07K2317/34—Identification of a linear epitope shorter than 20 amino acid residues or of a conformational epitope defined by amino acid residues
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2740/00—Reverse transcribing RNA viruses
    • C12N2740/00011—Details
    • C12N2740/10011—Retroviridae
    • C12N2740/16011—Human Immunodeficiency Virus, HIV
    • C12N2740/16111—Human Immunodeficiency Virus, HIV concerning HIV env
    • C12N2740/16122—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Virology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Genetics & Genomics (AREA)
  • Oncology (AREA)
  • Biophysics (AREA)
  • Immunology (AREA)
  • AIDS & HIV (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Communicable Diseases (AREA)
  • Hematology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
DK91907077.1T 1990-04-03 1991-04-01 Fremgangsmåder og præparater til vaccination mod HIV DK0527760T3 (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US50478590A 1990-04-03 1990-04-03

Publications (1)

Publication Number Publication Date
DK0527760T3 true DK0527760T3 (da) 1995-11-27

Family

ID=24007729

Family Applications (1)

Application Number Title Priority Date Filing Date
DK91907077.1T DK0527760T3 (da) 1990-04-03 1991-04-01 Fremgangsmåder og præparater til vaccination mod HIV

Country Status (10)

Country Link
US (2) US5674984A (da)
EP (1) EP0527760B1 (da)
JP (1) JP3494300B2 (da)
AT (1) ATE125157T1 (da)
AU (2) AU647108B2 (da)
CA (1) CA2078546A1 (da)
DE (1) DE69111440T2 (da)
DK (1) DK0527760T3 (da)
NZ (1) NZ237666A (da)
WO (1) WO1991015238A1 (da)

Families Citing this family (37)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5614612A (en) * 1990-03-09 1997-03-25 Haigwood; Nancy L. Purified gp120 compositions retaining natural conformation
HUT66445A (en) * 1990-10-26 1994-11-28 New York Health Res Inst Monoclonal antibodies specific for the v3 loop and cd-4 binding site of hiv-1 gp120
FR2676071B1 (fr) * 1991-05-02 1994-11-18 Transgene Sa Nouveau variant gp160 non-clivable, soluble, de forme hybride.
AU700371B2 (en) 1993-06-07 1999-01-07 Genentech Inc. Hiv envelope polypeptides
US6913767B1 (en) 1993-10-25 2005-07-05 Genentech, Inc. Compositions for microencapsulation of antigens for use as vaccines
US5643605A (en) * 1993-10-25 1997-07-01 Genentech, Inc. Methods and compositions for microencapsulation of adjuvants
DE4405810A1 (de) 1994-02-23 1995-08-24 Behringwerke Ag Von einem Retrovirus aus der HIV-Gruppe abgeleitete Peptide und deren Verwendung
US5997861A (en) * 1994-10-31 1999-12-07 Burstein Laboratories, Inc. Antiviral supramolecules containing target-binding molecules and therapeutic molecules bound to spectrin
ZA975889B (en) * 1996-07-08 1998-02-23 Genentech Inc HIV envelope polypeptides and vaccine.
US6585979B1 (en) 1996-07-08 2003-07-01 Genentech, Inc. HIV envelope polypeptides and immunogenic composition
US6271198B1 (en) 1996-11-06 2001-08-07 Genentech, Inc. Constrained helical peptides and methods of making same
US6121021A (en) 1997-12-16 2000-09-19 Connaught Laboratories Limited Constitutive expression of non-infectious HIV-like particles
US6289229B1 (en) * 1998-01-20 2001-09-11 Scimed Life Systems, Inc. Readable probe array for in vivo use
ES2299276T3 (es) 1998-12-31 2008-05-16 Novartis Vaccines And Diagnostics, Inc. Polipeptidos env del vih modificados.
JP2003523721A (ja) 1998-12-31 2003-08-12 カイロン コーポレイション 抗原性ｈｉｖｃ型ポリペプチドをコードするポリヌクレオチド、ポリペプチド、およびそれらの使用
ES2303513T3 (es) 1999-11-16 2008-08-16 Geneart Ag Genoma del intersubtipo (c/b') de vih-1 y sus aplicaciones.
US7211659B2 (en) 2001-07-05 2007-05-01 Chiron Corporation Polynucleotides encoding antigenic HIV type C polypeptides, polypeptides and uses thereof
US20030170614A1 (en) 2001-08-31 2003-09-11 Megede Jan Zur Polynucleotides encoding antigenic HIV type B polypeptides, polypeptides and uses thereof
DE10255508A1 (de) * 2002-11-27 2004-06-17 Forschungszentrum Jülich GmbH Verfahren zur Kultivierung von Zellen zur Produktion von Substanzen
US7658927B2 (en) * 2003-05-12 2010-02-09 University Of Florida Research Foundation, Inc. Materials and methods for immunizing against FIV infection
JP2006528244A (ja) 2003-05-12 2006-12-14 ユニバーシティ オブ フロリダ リサーチ ファウンデーション，インコーポレイティド Ｆｉｖ感染予防接種のための材料と方法
US20110150911A1 (en) * 2003-11-19 2011-06-23 Qui-Lim Choo Methods and reagents for treating, preventing and diagnosing bunyavirus infection
US20100285062A1 (en) 2006-03-31 2010-11-11 Novartis Ag Combined mucosal and parenteral immunization against hiv
US8512947B2 (en) 2007-02-16 2013-08-20 Drexel University Detection of nucleic acids using a cantilever sensor
US7892759B2 (en) * 2007-02-16 2011-02-22 Drexel University Enhanced sensitivity of a cantilever sensor via specific bindings
KR102071834B1 (ko) 2009-10-26 2020-01-30 에프. 호프만-라 로슈 아게 글리코실화된 면역글로불린의 제조 방법
WO2011119920A2 (en) 2010-03-25 2011-09-29 Oregon Health & Science University Cmv glycoproteins and recombinant vectors
CN102552904A (zh) * 2010-12-23 2012-07-11 徐州医学院附属医院 人类免疫缺陷病毒膜分子gp120功能域与人TGF-β1的重组分子
HUE037408T2 (hu) 2011-06-10 2018-08-28 Univ Oregon Health & Science CMV glikoproteinek és rekombináns vektorok
US20130189754A1 (en) 2011-09-12 2013-07-25 International Aids Vaccine Initiative Immunoselection of recombinant vesicular stomatitis virus expressing hiv-1 proteins by broadly neutralizing antibodies
EP2586461A1 (en) 2011-10-27 2013-05-01 Christopher L. Parks Viral particles derived from an enveloped virus
ES2631608T3 (es) 2012-06-27 2017-09-01 International Aids Vaccine Initiative Variante de la glicoproteína Env del VIH-1
EP2848937A1 (en) 2013-09-05 2015-03-18 International Aids Vaccine Initiative Methods of identifying novel HIV-1 immunogens
US10058604B2 (en) 2013-10-07 2018-08-28 International Aids Vaccine Initiative Soluble HIV-1 envelope glycoprotein trimers
US10174292B2 (en) 2015-03-20 2019-01-08 International Aids Vaccine Initiative Soluble HIV-1 envelope glycoprotein trimers
US9931394B2 (en) 2015-03-23 2018-04-03 International Aids Vaccine Initiative Soluble HIV-1 envelope glycoprotein trimers
SG11202012043RA (en) 2018-07-03 2021-01-28 Gilead Sciences Inc Antibodies that target hiv gp120 and methods of use

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4725669A (en) * 1984-11-09 1988-02-16 President And Fellows Of Harvard College Assay for detecting infection by human T-cell lymphotropic virus-III
AU600658B2 (en) * 1984-12-24 1990-08-23 Genentech Inc. Molecularly cloned acquired immunodeficiency syndrome polypeptides and their methods of use
US5166050A (en) * 1986-08-20 1992-11-24 Bristol-Myers Squibb Company Monoclonal antibodies and peptides useful in treating and diagnosing HIV infections
IL89567A0 (en) * 1988-03-28 1989-09-10 Univ Leland Stanford Junior Mutated hiv envelope protein
EP0339504A3 (en) * 1988-04-26 1990-09-12 The Du Pont Merck Pharmaceutical Company Human immunodeficiency virus (hiv) env-coded peptide capable of eliciting hiv-inhibiting antibodies in mammals
AU3775789A (en) * 1988-06-10 1990-01-05 Applied Biotechnology, Inc. A method of evaluating recombinant vaccines against immunodeficiency virus
US5116740A (en) * 1988-08-16 1992-05-26 Akzo N.V. Method for producing native hiv gp160
AU6523590A (en) * 1989-09-22 1991-04-18 Idec Pharmaceuticals Corporation Novel peptides associated with the cd4 binding region of gp120 and their methods of use
DE69132795T3 (de) * 1990-03-09 2008-07-10 Novartis Vaccines and Diagnostics, Inc., Emeryville Gereinigtes gp120, in dem seine natürliche konformation erhalten bleibt
WO1993020104A1 (en) * 1992-03-31 1993-10-14 The Public Health Research Institute Of The City Of New York, Inc. Monoclonal antibodies against a carbohydrate-dependent epitope related to the v2 region of hiv-1 gp120

Also Published As

Publication number Publication date
US5674984A (en) 1997-10-07
NZ237666A (en) 1997-08-22
EP0527760B1 (en) 1995-07-19
AU647108B2 (en) 1994-03-17
ATE125157T1 (de) 1995-08-15
AU7584791A (en) 1991-10-30
EP0527760A1 (en) 1993-02-24
JP3494300B2 (ja) 2004-02-09
JPH05505611A (ja) 1993-08-19
WO1991015238A1 (en) 1991-10-17
AU5055593A (en) 1994-01-27
US5849533A (en) 1998-12-15
DE69111440T2 (de) 1996-03-28
CA2078546A1 (en) 1991-10-04
DE69111440D1 (de) 1995-08-24

Similar Documents

Publication Publication Date Title
DK0527760T3 (da) Fremgangsmåder og præparater til vaccination mod HIV
ATE328068T1 (de) Papillomavirus vakzine
DK614987A (da) Syntetiske htlv-iii peptider, praeparater og anvendelser deraf
MX9203439A (es) Una citocina mamifera, il-11
ATE481480T1 (de) Methoden und zusammensetzungen zur herstellung von polypeptiden
CY1107447T1 (el) Ετερολογη εκφραση πρωτεϊνων των neisseria
DE69534778D1 (en) Cathepsin-02-protease
DE3751506D1 (de) Verbinden von polikristallinen Diamantformkörpern bei niedrigem Druck.
ES2129487T3 (es) Peptidos sinteticos, anticuerpos dirigidos contra ellos y su utilizacion.
NO912825L (no) Fremgangsmaate for fremstilling av kokonjugatvaksiner omfattende im munogent protein, hiv-beslektede peptider og anioniske grupper.
IT8621106A0 (it) Vettore ad espressione e secrezione in lieviti, utile per lapreparazione di proteine eterologhe.
NO852567L (no) Thymopentinanaloger og fremgangsmmaate for deres fremstilling.
DK0771213T3 (da) Haemophilus influenza adhærens- og penetrationsproteiner
DK0480949T4 (da) Fremstilling af virusvaccine
DE69531235D1 (de) Säugetier - Expressionssysteme für Hüllenprotingene des Hepatitit - C - Virus
ITRM920350A1 (it) Epitopi immunologicamente omologhi di hla e proteine del virus hiv.
DE3854550D1 (de) HIV-Peptide und Methoden für den Nachweis von HIV.
DE69634077D1 (de) Haemophilus adhäsionsproteinen
DE69728897D1 (de) Saeugetierchemokine
DE69736779D1 (de) Zusammensetzungen von rekombinanten papillomavirus vakzinen
KR950700988A (ko) 미생물, 이들의 제조방법 및 이들의 사용(Micro-organisms, preparation method therefor and uses thereof)
ATE294237T1 (de) S?ugetier thymokingene
FI950248A0 (fi) Rokotteita monisoluisia loisia vastaan
DK0815141T3 (da) Antistof mod et fusionspolypeptid omfattende en histidinandel
DK8089D0 (da) Monoclonale antistoffer, deres fremstilling og anvendelse.